Abstract
In the past decade, the medical and oncological rationale for kidney-sparing surgical approaches for small renal masses has been clarified. Although radical nephrectomy is still necessary for many patients diagnosed with large renal tumours, accumulating evidence indicates that partial nephrectomy provides equivalent oncological outcomes while also preserving renal function and preventing the adverse cardiovascular effects of chronic kidney disease. Furthermore, approximately 45% of resected small renal tumours are benign or indolent, with limited—if any—metastatic potential. Patients who develop kidney cancer often have medical comorbidities that can affect kidney function, such as diabetes and hypertension, and histological examination of the non-tumour-bearing elements of the kidney demonstrate significant pathological changes in the vast majority of patients. For elderly patients or patients with comorbidities, active surveillance provides an alternative kidney-sparing approach, and is associated with extremely low rates of clinical disease progression and metastases. Despite these important advances in understanding, which support the use of partial nephrectomy for the treatment of small renal masses, the technique remains underused.
Key Points
-
Radical nephrectomy and partial nephrectomy provide equivalent oncological tumour control for the management of small (T1) renal masses
-
Approximately 45% of resected small renal tumours are benign or indolent, with limited metastatic potential
-
Radical nephrectomy is far more likely to cause or worsen pre-existing chronic kidney disease than partial nephrectomy
-
Chronic kidney disease—which is often present in patients with kidney tumours secondary to hypertension and diabetes—is associated with adverse cardiovascular events and poor overall survival
-
Despite strong clinical evidence supporting partial nephrectomy as the preferred surgical approach for small renal tumours, the technique is grossly underused
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Beare, J. B. & McDonald, J. R. involvement of renal capsule in surgically removed hypernephroma: a gross and histopathologic study. J. Urol. 61, 857–861 (1949).
Mortensen, H. Transthoracic nephrectomy. J. Urol. 60, 855–858 (1948).
Robson, C. J. Radical nephrectomy for renal cell carcinoma. J. Urol. 89, 37–42 (1963).
Robson, C. J., Churchill, B. M. & Andersen, W. The results of radical nephrectomy for renal cell carcinoma. J. Urol. 101, 297–301 (1969).
Skinner, D. G., Colvin, R. B., Vermillion, C. D., Pfister, R. C. & Leadbetter, W. F. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 28, 1165–1177 (1971).
Patel, N. P. & Lavengood, R. W. Renal cell carcinoma: natural history and results of treatment. J. Urol. 119, 722–726 (1978).
Sagalowsky, A. I., Kadesky, K. T., Ewalt, D. M. & Kennedy, T. J. Factors influencing adrenal metastasis in renal cell carcinoma. J. Urol. 151, 1181–1184 (1994).
Herrlinger, A., Schrott, K. M., Schott, G. & Sigel, A. What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma. J. Urol. 146, 1224–1227 (1991).
Ditonno, P., Traficante, A., Battaglia, M., Grossi, F. S. & Selvaggi, F. P. Role of lymphadenectomy in renal cell carcinoma. Prog. Clin. Biol. Res. 378, 169–174 (1992).
Robson, C. J. Results of radical thoraco-abdominal nephrectomy in the treatment of renal cell carcinoma. Proc. Clin. Biol. Res. 100, 481–488 (1982).
Russo, P. in Genitourinary Oncology 3rd edn (ed. Vogelzang, N. J.) 725–731 (Lippincott Williams and Wilkins, Philadelphia, 2006).
Herr, H. W. A history of partial nephrectomy for renal tumors. J. Urol. 173, 705–708 (2005).
Herr, H. W. Surgical management of renal tumors: a historical perspective. Urol. Clin. N. Am. 35, 543–549 (2008).
Boyce, W. H. & Elkins, I. B. Reconstructive renal surgery following anatrophic nephrolithotomy: Followup of 100 consecutive cases. J. Urol. 111, 307–312 (1974).
Brödel, M. The intrinsic blood vessels of the kidney and their significance in nephrotomy. Johns Hopkins Hosp. Bull. 12, 10–13 (1901).
Woodhouse, C. R., Farrell, C. R., Paris, A. M. & Blandy, J. P. The place of extended pyelolithotomy (Gil-Vernet Operation) in the management of renal staghorn calculi. Br. J. Urol. 53, 520–523 (1981).
McAninch, J. W. & Carroll, P. R. Renal exploration after trauma. Indications and reconstructive techniques. Urol. Clin. North Am. 16, 203–212 (1989).
Russo, P. The role of surgery in the management of early-stage renal cancer. Hematol. Oncol. Clin. North Am. 25, 737–752 (2011).
Licht, M. R. & Novick, A. C. Nephron sparing surgery for renal cell carcinoma. J. Urol. 149, 1–7 (1993).
Herr, H. W. Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year followup. J. Urol. 161, 33–35 (1999).
Fergany, A. F., Hafez, K. S., & Novick, A. C. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J. Urol. 163, 442–445 (2000).
Uzzo, R. G. & Novick, A. C. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J. Urol. 166, 6–18 (2001).
Russo, P. & Huang, W. The medical and oncological rationale for partial nephrectomy for treatment of T1 renal cortical tumors. Urol. Clin. North Am. 35, 635–643 (2008).
Lee, C. T. et al. Surgical management of renal tumors of 4 cm or less in a contemporary cohort. J. Urol. 163, 730–736 (2000).
Lessage, K., Joniau, S., Fransis, K. & Van Poppel, H. Comparison between open partial and radical nephrectomy for renal tumours: perioperative outcome and health-related quality of life. Eur. Urol. 51, 614–620 (2007).
Russo, P. et al. Partial Nephrectomy: the rationale for expanding the indications. Ann. Surg. Oncol. 9, 680–687 (2002).
Leibovich, B. C. et al. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J. Urol. 171, 1066–1070 (2004).
Dash, A. et al. Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4–7 cm. BJU Int. 97, 939–945 (2006).
Pahernik, S., Roos, F., Röhrig, B., Wiesner, C. & Thüroff, J. W. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm. J. Urol. 179, 71–74 (2008).
Thompson, H. R. et al. Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J. Urol. 182, 2601–2606 (2009).
Karellas, M. E., O'Brien, M. F., Jang, T. L., Bernstein, M. & Russo, P. Partial nephrectomy for selected renal cortical tumors of ≥7 cm. BJU Int. 106, 1484–1487 (2010).
Breau, R. H. et al. Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J. Urol. 183, 903–908 (2010).
Kattan, M. W., Reuter, V., Motzer, R. J., Katz, J. & Russo, P. A postoperative prognostic nomogram for renal cell carcinoma. J. Urol. 166, 63–67 (2001).
Lane, B. R. & Kattan, M. W. Prognostic models and algorithms in renal cell carcinoma. Urol. Clin. North Am. 35, 613–625 (2008).
Clayman, R. V. et al. Laparoscopic nephrectomy. N. Engl. J. Med. 324, 1370–1371 (1991).
Clayman, R. V. et al. Laparoscopic nephrectomy: Initial case report. J. Urol. 146, 278–282 (1991).
McDougall, E. M. et al. Laparoscopic partial nephrectomy in the pig model. J. Urol. 149, 1633–1636 (1993).
Winfield, H. N., Donovan, J. F., Godet, A. S. & Clayman, R. V. Laparoscopic partial nephrectomy: initial case report for benign disease. J. Endourol. 7, 521–526 (1993).
Benway, B. M. et al. Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes. J. Urol. 182, 866–72 (2009).
Haber, G. P. et al. Robotic versus laparoscopic partial nephrectomy: Single-surgeon matched cohort study of 150 patients. Urology 76, 754–758 (2010).
Mir, S. A., Cadeddu, J. A., Sleeper, J. P. & Lotan, Y. Cost comparison of robotic, laparoscopic, and open partial nephrectomy. J. Endourol. 25, 447–453 (2011).
Segev, D. L. et al. Perioperative mortality and long-term survival following live kidney donation. JAMA 303, 959–966 (2010).
Fehrman-Ekholm, I. et al. No evidence of accelerated loss of kidney function in living kidney donors: results from a cross-sectional follow up. Transplantation 72, 444–449 (2001).
Goldfarb, D. A. et al. Renal outcome 25 years after donor nephrectomy. J. Urol. 166, 2043–2047 (2001).
Kaplan, C., Pasternack, B., Shah, H. & Gallo, G. Age-related incidence of sclerotic glomeruli in human kidneys. Am. J. Pathol. 80, 227–234 (1975).
Lau, W. K., Blute, M. L., Weaver, A. L., Torres, V. E. & Zincke, H. Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin. Proc. 75, 1236–1242 (2000).
McKiernan, J., Simmons, R., Katz, J. & Russo, P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59, 816–820 (2002).
Sarnak, M. J. et al. Kidney disease as a risk factor for the development of cardiovascular disease: a statement from the American Heart Association Council on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108, 2154–2169 (2003).
Chobanian, A. V. et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289, 2560–2572 (2003).
National Kidney Foundation. K/DOQI clinical guideline for chronic kidney disease evaluation, classification, stratification. Am. J. Kidney Dis. 39 (Suppl. 1), S1–S266 (2002).
Ritz, E. & McClellan, W. M. Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences. J. Am. Soc. Nephrol. 15, 513–516 (2004).
Shlipak, M. G. et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293, 1737–1745 (2005).
Coresh, J. et al. Prevalence of chronic kidney disease in the United States. JAMA 298, 2038–2047 (2007).
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296–1305 (2004).
Foley, R. N., Wang, C. & Collins, A. J. Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study. Mayo Clin. Proc. 80, 1270–1277 (2005).
Stevens, L. A., Coresh, J., Greene, T. & Levey, A. S. Assessing kidney function—measured and estimated glomerular filtration rate. N. Engl. J. Med. 354, 2473–2483 (2006).
Fadem, S. Z. & Rosenthal, B. CKD-EPI & MDRD study equation calculator. The Nephron Information Center [online], (2011).
Huang, W. C. et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumors: a retrospective cohort study. Lancet Oncol. 7, 735–740 (2006).
Thompson, R. H. et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J. Urol. 179, 468–473 (2008).
Huang, W. C., Elkin, E. B., Levey, A. S., Jang, T. L. & Russo, P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors—is there a difference in mortality and cardiovascular outcomes? J. Urol. 181, 55–62 (2009).
Tan, H. J. et al. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA 307, 1629–1635 (2012).
Kim, S. P. et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: A systematic review and meta-analysis. J. Urol. 188, 51–57 (2012).
Foyil, K. V. et al. Longterm changes in creatinine clearance after laparoscopic renal surgery. J. Am. Coll. Surg. 206, 511–515 (2008).
Van Poppel, H. et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur. Urol. 59, 543–552 (2011).
Lane, B. R., Poggio, E. D., Herts, B. R., Novick, A. C. & Campbell, S. C. Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J. Urol. 182, 435–444 (2009).
Campbell, S. C. et al. Guideline for management of the clinical T1 renal mass. J. Urol. 182, 1271–1279 (2009).
Bijol, V., Mendez, G. P., Hurwitz, S., Rennke, H. G. & Nosé, V. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens; predicting the risk of progressive renal failure. Am. J. Surg. Pathol. 30, 575–584 (2006).
Henriksen, K. J., Meehan, S. M. & Chang, A. Nonneoplastic kidney diseases in adult tumor nephrectomy and nephroureterectomy specimens: common, harmful, yet underappreciated. Arch. Pathol. Lab. Med. 133, 1012–1025 (2009).
Bonsib, S. M. & Pei, Y. The non-neoplastic kidney in tumor nephrectomy specimens: what can it show and what is important? Adv. Anat. Pathol. 17, 235–250 (2010).
Mandayam, S. & Shahinian, V. B. Are chronic dialysis patients at increased risk for cancer? J. Nephrol. 21, 166–174 (2008).
Buell, J. F., Gross, T. G. & Woodle, E. S. Malignancy after transplantation. Transplantation 80 (Suppl. 1), S254–S264 (2005).
Birkeland, S. A., Lokkegaard, H. & Storm, H. H. Cancer risk in patients on dialysis and after renal transplantation. Lancet 355, 1886–1887 (2000).
Tickoo, S. K. et al. Spectrum of epithelial neoplasms in end stage renal disease: An experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am. J. Surg. Pathol. 30, 141–153 (2006).
Ishikawa, I. & Kovacs, G. High incidence of papillary renal cell tumors in patients on chronic haemodialysis. Histopathology 22, 135–139 (1993).
Neuzillett, Y. et al. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur. Urol. 60, 366–373 (2011).
Hora, M. et al. Tumors in end-stage kidney. Transplant Proc. 40, 3354–3358 (2008).
Hajj, P. et al. Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology 74, 631–634 (2009).
Weng, P. H. et al. Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort. Clin. J. Am. Soc. Nephrol. 6, 1121–1128 (2011).
Wong, G. et al. Association of CKD and cancer risk in older people. J. Am. Soc. Nephrol. 20, 1341–1350 (2009).
Stengel, B. Chronic kidney disease and cancer: a troubling connection. J. Nephrol. 23, 253–262 (2010).
Dou, L. et al. P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines. Kidney Int. 62, 1999–2009 (2002).
Faure, V. et al. The uremic solute p-cresol decreases leukocyte transendothelial migration in vitro. Int. Immunol. 10, 1453–1459 (2006).
Hollenbeck, B. K., Taub, D. A., Miller, D. C., Dunn, R. L. & Wei, J. T. National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 67, 254–259 (2006).
Miller, D. C., Hollingsworth, J. M., Hafez, K. S., Daignault, S. & Hollenbeck, B. K. Partial nephrectomy for small renal masses: an emerging quality of care concern? J. Urol. 175, 853–858 (2006).
Dulabon, L. M., Lowrance, W. T., Russo, P. & Huang, W. C. Trends in renal tumor surgery delivery within the United States. Cancer 116, 2316–2321 (2010).
Lowrance, W. T. et al. Complications after radical and partial nephrectomy as a function of age. J. Urol. 183, 1725–1730 (2010).
Miller, D. C., Taub, D. A., Dunn, R. L., Wei, J. T. & Hollenbeck, B. K. Laparoscopy for renal cell carcinoma: diffusion versus regionalization? J. Urol. 176, 1102–1107 (2006).
Nuttall, M. et al. A description of radical nephrectomy practice and outcomes in England. 1995–2002. BJU Int. 96, 58–61 (2005).
Thompson, R. H. et al. Contemporary use of partial nephrectomy at a tertiary care center in the United States. J. Urol. 181, 993–997 (2009).
Smaldone, M. C., Egleston, B., Uzzo, R. G. & Kutikov, A. Does partial nephrectomy result in durable overall survival benefit in the medicare population? J. Urol. 188, 2089–2094 (2012).
Sun, M. et al. Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities. BJU Int. 111, 67–73 (2013).
Smaldone, M. C. et al. Small renal masses progressing to metastases under active surveillance: a systemic review and pooled analysis. Cancer 118, 997–1006 (2012).
Lane, B. R. et al. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older. Cancer 116, 3119–3126 (2010).
Reyes, J. et al. Thermal ablation of the small renal mass: Case selection using the R.E.N.A.L-Nephrometry Score. Urol. Oncol. doi:10.1016/j.urolonc.2011.09.006.
Kunkle, D. A., Egleston, B. L. & Uzzo, R. G. Excise, ablate, or observe: the small renal mass dilemma—a meta-analysis and review. J. Urol. 179, 1227–1234 (2008).
Russo, P. Renal cryoablation. Study with care. Proceed with caution. Urology 65, 419–421 (2005).
Best, S. L. et al. Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters. J. Urol. 187, 1183–1189 (2012).
Young, E. E., Castle, S. M., Gorbatiy, V. & Leveillee, R. J. Comparison of safety, renal function outcomes and efficacy of laparoscopic and percutaneous radio frequency ablation of renal masses. J. Urol. 187, 1177–1182 (2012).
Stein, A. J. et al. Persistent contrast enhancement several months after laparoscopic cryoablation of the small renal mass may not indicate recurrent tumor. J. Endourol. 11, 2433–2439 (2008).
Breda, A., Anterasian, C. & Belldegrun, A. Management and outcomes of tumor recurrence after focal ablation renal therapy. J. Endourol. 24, 749–752 (2010).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Russo, P. Oncological and renal medical importance of kidney-sparing surgery. Nat Rev Urol 10, 292–299 (2013). https://doi.org/10.1038/nrurol.2013.34
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2013.34
This article is cited by
-
Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma
Nature Reviews Urology (2022)
-
Current Status of Nephron-Sparing Surgery (NSS) in the Management of Renal Tumours
Indian Journal of Surgical Oncology (2017)
-
Non-neoplastic parenchymal changes in kidney cancer and post-partial nephrectomy recovery of renal function
International Urology and Nephrology (2015)